Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
Showing news related to
fas controlled t cells drive lymphoproliferation through glycolysis without effector differentiation
Original title: “FAS-controlled T cells drive lymphoproliferation through glycolysis without effector differentiation.”
spectrum pathobiology mechanistic insights and diagnostic challenges of post car t cell therapy lymphoproliferative disorders
Original title: “Spectrum, pathobiology, mechanistic insights and diagnostic challenges of post-CAR T cell therapy lymphoproliferative disorders.”